Edwards Lifesciences EW Other countries — Operating Loss Carryforwards, Valuation Allowance

Similar metrics at other companies

PLDOther Countries — Operating Loss Carryforwards Valuation Allowance

$8.61M+7.7%

WTWNon Us — Operating Loss Carryforwards Valuation Allowance

$24M+50.0%

VIRTOperating Loss Carryforwards And Tax Credits Valuation Allowance

$7.88M-23.7%

LILAUnited States — Valuation allowance of net operating loss carryforwards

$13M+44.4%

FNFTitle — Operating loss carryforwards, valuation allowance

$25M0.0%

GOROUS — Operating Loss Carryforwards Valuation Allowance

$18.1M+5.2%

Questions, answered.

What is Edwards Lifesciences's other countries — operating loss carryforwards, valuation allowance?

Edwards Lifesciences (EW) reported other countries — operating loss carryforwards, valuation allowance of $74.6M in Q4 2025.

How has Edwards Lifesciences's other countries — operating loss carryforwards, valuation allowance changed year-over-year?

Edwards Lifesciences's other countries — operating loss carryforwards, valuation allowance increased by 18.0% year-over-year, from $63.2M to $74.6M.

What does other countries — operating loss carryforwards, valuation allowance mean?

The valuation allowance established against deferred tax assets related to operating loss carryforwards in international jurisdictions. This represents the portion of tax assets that management believes is more likely than not to remain unrealized due to insufficient future taxable income in those specific regions.